Navigation Links
MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer
Date:5/13/2011

BETHEL, Conn., May 13, 2011 /PRNewswire/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN), the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has formed a co-marketing agreement with Covidien, a leading global healthcare products company.

With this relationship, Covidien's national sales force for SharpSafety products will promote MedClean products and services in a complimentary manner to MedClean's existing Distributor sales force. As a result of this relationship with Covidien, and the MedAssets relationships already in place, MedClean will have multiple sales professionals promoting the Company in nearly every hospital in the U.S. In addition, MedClean will sell and distribute Covidien's market-leading sharps and waste containers.

"This relationship is our largest co-promotion arrangement to date, broadening the exposure of our products and connecting MedClean with nearly every hospital in the country," commented David Laky, MedClean's President and CEO.  "One of the goals of this co- promotion relationship is to ensure the market is educated about disposable sharps versus reusable sharps and the benefits, through safety and expense reduction, that disposable sharps programs provide to healthcare facilities. We estimate the market for sharps containers to exceed $280million annually, and capturing a significant share of this market is a priority for both companies. We are excited to collaborate with Covidien and look forward to a long and mutually productive relationship."

MedClean now has approximately 98 sales professionals in 50 states plus Canada promoting the Company's innovative Technology enabled Solutions (TeS) for the treatment and disposal of medical waste and the destruction of confidential documents and related media.

"The extended sales cycle and the process for educating sales professionals on the benefits and details of our systems takes about six to nine months," added Mr. Laky. "We continue to see distributors ramping up their lead generation efforts over this time frame, and as such we believe we will see an acceleration of our sales in the coming quarters due to the many relationships we have brought on board in the last year."

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

CONTACT:  Cameron Donahue
Hayden IR
(651) 653-1854


'/>"/>
SOURCE MedClean Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedClean Technologies Announces 2010 Results
2. MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables
3. MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems
4. MedClean Technologies Announces Second Quarter Results
5. Medical Care Technologies Inc. Selects Geographical Location for Flagship Childrens Health Center
6. Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
7. Cell Biosciences Acquires Brightwell Technologies
8. Life Technologies Announces Redemption of 3.25% Convertible Senior Notes Due 2025
9. BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets Seventh Annual Equity Conference
10. Applied Isotope Technologies Opens New Facility in PLSG Life Sciences Campus
11. Reportlinker Adds Markets for Emerging Pharmaceutical Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):